Dr. Cathy Kelly is a Consultant Medical Oncologist at the Mater Misericordiae University Hospital, Dublin, and Cavan General Hospital. Dr Kelly is Chair of Cancer Trials Ireland, Breast Cancer Clinical Trials Group and a Clinical Lecturer in UCD. She received her postgraduate training in Canada (Sunnybrook Odette Cancer Center, Toronto) and USA (MD Anderson, Texas). She has Fellowships in Medical Oncology and Breast Medical Oncology from Toronto-Sunnybrook, Odette Cancer Center, Canada and The University of Texas, M.D Anderson Cancer Center, Houston, USA (competitively awarded the Susan G. Komen Interdisciplinary breast cancer fellowship). She is an expert in breast cancer and oncology biomarkers, particularly those for early stage breast cancer. She is widely published in breast cancer with over 40 peer reviewed publication in journals such as JCO, JNCI, The Oncologist, BMJ, Lancet Oncology and Breast Cancer Research, Cancer. Notably she prepared the evidence based report supporting the reimbursement of Oncotype DX on behalf of the Irish Society of Medical Oncology.